发明名称 Stabilized tolterodine tartrate formulations
摘要 A method of making a pharmaceutical composition containing tolterodine L-tartrate stabilized against degradation with an acid. Acid-stabilized tolterodine L-tartrate may be used as an active ingredient in various types of immediate release and controlled release dosage forms, including tablets, capsules, and beads.
申请公布号 US8778397(B2) 申请公布日期 2014.07.15
申请号 US201313915367 申请日期 2013.06.11
申请人 Mylan, Inc. 发明人 Rossi David T.;Li Boyong;McCall James Paul
分类号 A61K31/135;A61K9/20;A61K9/24;A61P43/00 主分类号 A61K31/135
代理机构 Kramer Amado, P.C. 代理人 Kramer Amado, P.C.
主权项 1. A method of making a drug-containing bead, said method comprising the steps of: combining tolterodine-L-tartrate with a stabilizing amount of a pharmaceutically acceptable non-polymeric pH-modifying acid having a pKa of less than 5.0 to obtain an acid-stabilized tolterodine-L-tartrate composition which does not contain oxybutynin; depositing a seal layer on an inert core, said seal layer being formed from a non-polymeric hydrophobic material; and depositing a layer containing said acid-stabilized tolterodine-L-tartrate on said seal layer.
地址 Morgantown WV US